Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Lastra, Rodrigo et al., 2026
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/230253

Oncology with common sense: beyond biologistic and pharmacological models

Títol de la revista

Director/Tutor

Contribució addicional

ISSN de la revista

Títol del volum

Resum

Rapid advances in oncology have led to unprecedented pharmacological and technological complexity, yet these developments have not always translated into meaningful benefits for patients. Inspired by the Common Sense Oncology movement, this article reflects on the need to recalibrate cancer care beyond biologistic and industry-driven models. We argue for a broader, patient-centred vision of oncology that integrates social determinants of health, prevention, supportive and palliative care, shared decision-making and independent research alongside pharmacological innovation. Drawing on evidence from health economics, clinical research trends and public health, we highlight the paradox between rising oncology expenditures and limited gains in overall survival, quality of life and equity. We also discuss the growing influence of industry-sponsored research, the increasing reliance on surrogate endpoints, and the underfunding of non-pharmacological and psychosocial interventions. Finally, we propose concrete priorities for policymakers, clinicians and research institutions to ensure that oncology progress remains aligned with outcomes that truly matter to patients.

Citació

Citació

LASTRA, Rodrigo, et al. Oncology with common sense: beyond biologistic and pharmacological models. ecancermedicalscience. 2026. Vol. 20, num. 2059. ISSN 1754-6605. [consulted: 20 of November of 2026]. Available at: https://hdl.handle.net/2445/230253

Exportar metadades

JSON - METS

Compartir registre